Approval · Notice of Compliance 1042 · 2000
BONEFOS: Notice of Compliance 1042
Issued August 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1042
- Date
- August 1, 2000
- Company
- Rhone-Poulenc Rorer Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONEFOS | Not yet assigned | — |
Medicinal ingredients
- DISODIUM CLODRONATE TETRAHYDRATE 400 MG per CAP
- DISODIUM CLODRONATE TETRAHYDRATE 60 MG per ML